[vc_row top_margin=”none” el_position=”first”] [vc_column top_margin=”none”] [mc_carousel id=”carousel” carousel_images=”2773,2772,2771,2770″ features_images_loop=”1″ lightbox_icon_color=”blue_light” autoplay=”0″ pause_on_hover=”1″ scroll=”1″ effect=”scroll” easing=”swing” duration=”500″ top_margin=”page_margin_top_section” el_position=”first last”] [/vc_column] [/vc_row] [vc_row top_margin=”none” el_position=”last”] [vc_column top_margin=”none”] [vc_column_text el_position=”first last”]
Biomarkers to Personalize Treatment of Head and Neck Cancer
March, 2018
https://www.technologynetworks.com/tn/news/biomarkers-to-personalize-treatment-of-head-and-neck-cancer-298587
Lower Radiation Doses Feasible for HPV-Positive Head and Neck Cancers
February 16, 2018
https://www.healio.com/hematology-oncology/head-neck-cancer/news/online/%7Bfa4c9f60-444f-4827-be5f-6c3fc3ff89c9%7D/lower-radiation-doses-feasible-for-hpv-positive-head-and-neck-cancers
Nivolumab Plus Chemoradiation Safe For Advanced Head, Neck Cancer
February 15, 2018
https://www.healio.com/hematology-oncology/head-neck-cancer/news/online/%7Beb07b2d1-3450-424d-9221-9a290f0fe29b%7D/nivolumab-plus-chemoradiation-safe-for-advanced-head-neck-cancer
Opdivo Safe for Head and Neck Cancer Patients on Radiation and Chemo, Phase 1 Trial Shows
February, 2018
https://immuno-oncologynews.com/2018/02/19/opdivo-safe-head-neck-cancer-radiation-chemotherapy/
Phase 2 Trial to Evaluate Combo of Imprime PGG, Keytruda in Head and Neck Cancer
February, 2018
https://immuno-oncologynews.com/2018/02/14/study-tests-combo-imprime-pgg-keytruda-head-neck-cancer/
The US Food and Drug Administration have given the OK for doctors to use Lymphoseek – a radioactive diagnostic imaging agent – to evaluate the spread of squamous cell carcinoma in the body’s head and neck region.
http://www.medicalnewstoday.com/articles/278302.php
France is 17th country to allow patient enrollment in head, neck cancer trial
Drug Discovery and Development
July 31, 2014
http://www.dddmag.com/news/2014/07/france-17th-country-allow-patient-enrollment-head-neck-cancer-trial
[/vc_column_text] [/vc_column] [/vc_row]